Compassionate Use of Stiripentol in Intractable Epilepsy Due to Dravet Syndrome.

Trial Profile

Compassionate Use of Stiripentol in Intractable Epilepsy Due to Dravet Syndrome.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Stiripentol (Primary)
  • Indications Dravet syndrome; Epilepsy
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 16 Jun 2017 Last checked against ClinicalTrials.gov record.
    • 27 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 18 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top